Drug tablet
Latest The Upjohn Company Patents:
- 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1-pyrazolo[4,3-]pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof
- CRYSTALLINE FORMS OF 3-[5-CHLORO-4-[(2,4-DIFLUOROBENZYL) OXY]-6-OXOPYRIMIDIN-1(6H)-YL]-N-(2-HYDROXYETHYL)-4-METHYLBENZAMIDE
- Anti-bacterial Vaccine Compositions
- Cellular permissivity factor for viruses and uses thereof
- METHOD OF ADMINISTERING AN INJECTABLE ANTIBIOTIC TO AN ANIMAL
Description
FIG. 1 is a top and front perspective view of a drug tablet showing my new design;
FIG. 2 is a bottom and front perspective view thereof;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a front elevational view thereof, the rear elevational view being identical thereto; and
FIG. 6 is a left end elevational view thereof, the right end elevational view being identical thereto.
Referenced Cited
Patent History
Patent number: D309035
Type: Grant
Filed: Mar 30, 1989
Date of Patent: Jul 3, 1990
Assignee: The Upjohn Company (Kalamazoo, MI)
Inventors: Phillip F. Ni (Mattawan, MI), Larry F. Odar (Galesburg, MI)
Primary Examiner: Wallace R. Burke
Assistant Examiner: Kay H. Chin
Law Firm: Flynn, Thiel, Boutell & Tanis
Application Number: 7/331,882
Type: Grant
Filed: Mar 30, 1989
Date of Patent: Jul 3, 1990
Assignee: The Upjohn Company (Kalamazoo, MI)
Inventors: Phillip F. Ni (Mattawan, MI), Larry F. Odar (Galesburg, MI)
Primary Examiner: Wallace R. Burke
Assistant Examiner: Kay H. Chin
Law Firm: Flynn, Thiel, Boutell & Tanis
Application Number: 7/331,882
Classifications
Current U.S. Class:
D28/2;
Jeweled (D28/81)